Dr. Peter Kador, Professor at the University of Nebraska Medical Center and President/CEO atTherapeutic Vision, Inc., has been appointed as “Best in Medicine” by the American Health Council. He will be sharing his knowledge and expertise in Healthcare Education, Workforce Development, Business, Leadership, Management, and Ophthalmology.
Dr. Kador has been active in the healthcare industry for the last 41 years and in his current role for the last 15. He obtained his Bachelor’s degree from Capital University in 1972 and his PhD in Medicinal and Pharmaceutical Chemistry from Ohio State University in 1976.
Established by Dr. Kador, Therapeutic Vision, Inc. focuses on the development of pharmaceuticals aiding the companion animal market along with their owner. With a team consisting of cataract development healthcare professionals, Therapeutic Vision, Inc. provides contract toxicological research services evaluating the effects of drugs on lens opacity and cataract formation.
Dr. Kador’s day-to-day responsibilities include data analysis, grant writing, strategic planning, management, and clinical research. He attributes his successful career to having a passion for the field along with hard work and good mentors. He is a Fellow of the American Association of Pharmaceutical Scientists and a Fellow of the Association for Research in Vision and Ophthalmology, as well as President, Treasurer, and Trustee of the Association for Ocular Pharmacology and Therapeutics.
Dr. Kador’s long-term professional goals include continued growth in the field and the development of Kinostat and multifunctional antioxidants. His awards and honors include: Rohto Foundation Cataract Research Award recipient, May 1981; Foundation for the Advancement of Science Fellow sponsored by Ayerst Research Laboratories, Inc., 1983-1984, 1984-1985; Alcon Foundation Research Award, recipient April 1986; Juvenile Diabetes Foundation Research Award, 1986 & 1987; Kinoshita Lectureship, National Foundation for Eye Research, Kona, Hawaii, November 1995; Foundation for the Advancement of Science Research Award sponsored by Pfizer Pharmaceuticals, 1998; Fellow, American Association of Pharmaceutical Scientists, Nov. 2004; Japanese Cataract Cooperative Research Group Award, Nov. 2005; Fellow, Association for Research in Vision and Ophthalmology, 2010; Distinguished Scientist, University of Nebraska Medical Center, 2010; Ernst H. Bárány Prize, International Society of Eye Research, Berlin, Germany, 2012; Columbus Technical Council Science Student of the Year, 1968; International Science Fair, Detroit MI, Fourth Award, 1968; Ford-Future Scientists of America Regional Award, 1968; Central Ohio Heart Association Undergraduate Research Scholarship “Effect of Various Honeybee Extracts on Black Bee Disease”, 1970-71; Central Ohio Heart Association Undergraduate Research Scholarship “O-Alkyldiglyceride Analysis in Rat Adipose Tissue”, 1971-72; National Institutes of Health Pre-Doctoral Trainee in Medicinal Chemistry, 1972-76; Alumni Achievement Award of Capital University, May 1990; Jack Beal Postbaccalaureate Alumni Achievement Award, Ohio State University College of Pharmacy, Columbus, Ohio, May 1992; and Bundesverdienstkreuz (Federal Cross of Merit) from the German Government, German Embassy, Washington, DC. Nov. 1994.
Dr. Kador was the youngest researcher to be appointed to the permanent research staff (1979) and subsequently retired in 2002 as Chief of Ocular Therapeutics from National Eye Institute, National Institutes of Health. He established the German-American Golf Tournament in Washington, D.C. (1995-2002) and was President of the Washington Saengerbund for 12 years.
Dr. Kador is Executive Vice-President of the National Foundation for Eye Research. He is a member of the American Chemical Society, Medicinal Chemical Division, Association for Ocular Pharmacology and Therapeutics, Association for Research in Vision and Ophthalmology, American Association of Pharmaceutical Scientists, American Diabetes Association, European Association for the Study of Diabetes, European Vision and Eye Research, International Diabetes Federation, International Society for Eye Research, and Sigma Xi Research Society.
In his free time, Dr. Kador enjoys golf and music.
Share this entry
Professor at the University of Nebraska, Department of Pharmaceutical Sciences
- Dr. Kador lectures on Medicinal Chemistry at both the professional and graduate student level and has elective courses for professional students on ophthalmic drugs and diabetic complications.
- In addition he lectures at the graduate level on Ophthalmic Research and Ocular Pharmacology.
- Dr. Kador’s laboratory is focused on the design and synthesis of multifunctional antioxidants and enzyme inhibitors, the mechanism of action of drugs and the development of agents as they relate to the inhibition of diabetic complications, and age related macular degeneration, cataract development and neurodegeneration including Alzheimer’s disease.
President/CEO at Therapeutic Vision, Inc.
- Focuses on the development of pharmaceuticals aiding the companion animal market along with their owner
- Dr. Kador is internationally recognized as an expert of cataract formation, ocular diabetic complications, ocular pharmacology and toxicology of the lens.
- Therapeutic Vision, Inc. provides contract toxicological research services evaluating the effects of drugs on lens opacity and cataract formation.